Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02900833

Impact of Neutrophil Activation in Acute Ischemic Stroke Patients Treated With Endovascular Therapy

Neutrophil Activation in Acute Ischemic Stroke Patients Treated With Endovascular Therapy

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
440 (estimated)
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Clinical and experimental data suggest that neutrophil activation and extravasation are deleterious in acute ischemic stroke (AIS) involving an increased risk of unfavorable outcome and hemorrhagic transformation (HT). However, clinical trials targeting neutrophil recruitment in AIS patients were negative. Recently, an experimental study has shown that neutrophil activation and transmigration begin immediately after the occlusion. Inhibition of neutrophil recruitment several hours after the start of ischemia appears therefore too late to have a clinical relevance. The objective is to study the time dependent impact of neutrophils in AIS and the predominant mediators in each time point to identify the appropriate therapeutic target and time window.

Conditions

Timeline

Start date
2016-03-24
Primary completion
2022-12-12
Completion
2026-08-31
First posted
2016-09-14
Last updated
2026-01-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02900833. Inclusion in this directory is not an endorsement.